Coronary collaterals—insights in molecular determinants and prognostic relevance von Regieli, J.J, Nathoe, H.M, Koerselman, J, van der Graaf, Y, Grobbee, D.E, Doevendans, P.A

Volltext

Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial von van der Baan, F H, Knol, M J, Maitland-van der Zee, A H, Regieli, J J, van Iperen, E P A, Egberts, A C G, Klungel, O H, Grobbee, D E, Jukema, J W

Volltext

Towards personalized treatment in cardiovascular disease : a molecular epidemiological approach von Regieli, J.J

Volltext bestellen

Clinical trial update III: Barcelona, 4 September 2006 von Regieli, J J

Volltext

Deciduous teeth as an alternative DNA source for postmortem genetic testing von Rijdt, W.P. te, Mieremet, R.H.P., Kraaijenbrink, T., Regieli, J.J., Lemmink, H.H., Jan, S.Z., Knijff, P. de, Hoedemaekers, Y.M.

Volltext bestellen

Absence of Connexin 40 gene polymorphism, as a marker of undetected atrial fibrillation in patients with unexplained cerebral ischemic events von Chaldoupi, Sevasti-Maria, Soedamah-Muthu, Sabita S., Regieli, Jakub, Werf, Christian van de, Nelen, Marcel, van der Smagt, Jasper J., Algra, Ale, Hauer, Richard N.W., Doevendans, Pieter A., Loh, Peter

Volltext

The first titin (c.59926+1G > A) founder mutation associated with dilated cardiomyopathy von Hoorntje, E.T., Spaendonck-Zwarts, K.Y. van, Rijdt, W.P.T., , L. boven, Vink, A., Smagt, J.J. van der, Asselbergs, F., Wijngaarden, J. van, Hennekam, E.A., Pinto, Y.M., Deprez, R.H.L., Barge-Schaapveld, D.Q.C.M., Bootsma, M., Regieli, J., Hoedemaekers, Y.M., Jongbloed, J.D.H., Berg, M.P. van den, Tintelen, J.P. van

Volltext bestellen